新光药业：关于持股5%以上股东减持股份的预披露公告

Core Viewpoint - Shengzhou Hefeng Investment Co., Ltd. plans to reduce its stake in New Light Pharmaceutical Co., Ltd. by up to 4,800,000 shares, representing a maximum of 3% of the company's total share capital [2] Summary by Category - Shareholding Details - Hefeng Investment holds 25,181,000 shares, accounting for 15.74% of the total share capital of New Light Pharmaceutical [2] - Reduction Plan - The reduction will occur within three months after the announcement date, starting 15 trading days from the announcement [2] - The reduction will be executed through centralized bidding or block trading [2] - Specifics of Share Reduction - Up to 1,600,000 shares (1% of total share capital) will be reduced via centralized bidding [2] - Up to 3,200,000 shares (2% of total share capital) will be reduced via block trading [2]